journal
MENU ▼
Read by QxMD icon Read
search

European Heart Journal

journal
https://www.readbyqxmd.com/read/28549118/an-unexpected-cause-of-angina-and-survived-sudden-cardiac-death
#1
Matthias P Nägele, Tardu Özkartal, Corinna Brunckhorst, Laurent Haegeli
No abstract text is available yet for this article.
May 26, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28549114/erratum
#2
(no author information available yet)
No abstract text is available yet for this article.
May 26, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28549109/il-18-cleavage-triggers-cardiac-inflammation-and-fibrosis-upon-%C3%AE-adrenergic-insult
#3
Han Xiao, Hao Li, Jing-Jing Wang, Jian-Shu Zhang, Jing Shen, Xiang-Bo An, Cong-Cong Zhang, Ji-Min Wu, Yao Song, Xin-Yu Wang, Hai-Yi Yu, Xiang-Ning Deng, Zi-Jian Li, Ming Xu, Zhi-Zhen Lu, Jie Du, Wei Gao, Ai-Hua Zhang, Yue Feng, You-Yi Zhang
Aims: Rapid over-activation of β-adrenergic receptor (β-AR) upon stress leads to cardiac inflammation, a prevailing factor that underlies heart injury. However, mechanisms by which acute β-AR stimulation induce cardiac inflammation still remain unknown. Here, we set out to identify the crucial role of inflammasome/interleukin (IL)-18 in initiating and maintaining cardiac inflammatory cascades upon β-AR insult. Methods and results: Male C57BL/6 mice were injected with a single dose of β-AR agonist, isoproterenol (ISO, 5 mg/kg body weight) or saline subcutaneously...
May 26, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28549103/coronary-artery-disease-physiology-and-prognosis
#4
Thomas J Ford, David Corcoran, Colin Berry
No abstract text is available yet for this article.
May 26, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28541494/understanding-the-role-of-genetics-in-hypertension
#5
Riyaz S Patel, Stefano Masi, Stefano Taddei
No abstract text is available yet for this article.
May 25, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28541452/clopidogrel-reloading-for-patients-with-acute-myocardial-infarction-already-on-clopidogrel-therapy
#6
Jacob A Doll, Shuang Li, Karen Chiswell, Matthew T Roe, Mikhail Kosiborod, Benjamin M Scirica, Tracy Y Wang
Aims: We sought to determine the association of clopidogrel reloading with in-hospital bleeding and mortality in contemporary practice. Methods and results: We examined clopidogrel reloading for ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI) patients on pre-admission clopidogrel therapy in the ACTION Registry-GWTG from 2009 to 2014. We used inverse probability weighted propensity adjustment to compare in-hospital mortality and major bleeding risks between patients reloaded in the first 24 h with ≥300 mg of clopidogrel vs...
May 25, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28535194/anomalous-origin-of-right-coronary-artery-from-the-pulmonary-artery
#7
Anders Svensson, Raquel Themudo, Kerstin Cederlund
No abstract text is available yet for this article.
May 23, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28531320/uk-biobank-opportunities-for-cardiovascular-research
#8
Thomas J Littlejohns, Cathie Sudlow, Naomi E Allen, Rory Collins
No abstract text is available yet for this article.
May 20, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28531282/near-infrared-spectroscopy-derived-lipid-core-burden-index-predicts-adverse-cardiovascular-outcome-in-patients-with-coronary-artery-disease-during-long-term-follow-up
#9
Anne-Sophie Schuurman, Maxime Vroegindewey, Isabella Kardys, Rohit M Oemrawsingh, Jin M Cheng, Sanneke de Boer, Hector M Garcia-Garcia, Robert-Jan van Geuns, Evelyn S Regar, Joost Daemen, Nicolas M van Mieghem, Patrick W Serruys, Eric Boersma, K Martijn Akkerhuis
Aims: Near-infrared spectroscopy (NIRS) is able to quantify cholesterol within coronary arteries by the lipid core burden index (LCBI). We studied the prognostic value of NIRS-derived LCBI in patients with coronary artery disease (CAD) for adverse cardiac outcome during long-term follow-up. Methods and results: During 2009-2013, NIRS was performed in a non-culprit artery of 275 patients undergoing coronary angiography for acute coronary syndrome (ACS) or stable angina...
May 20, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28531281/standard-vs-intensified-management-of-heart-failure-to-reduce-healthcare-costs-results-of-a-multicentre-randomized-controlled-trial
#10
P A Scuffham, J Ball, J D Horowitz, C Wong, P J Newton, P Macdonald, J McVeigh, A Rischbieth, N Emanuele, M J Carrington, C M Reid, Y K Chan, S Stewart
Aims: To determine if an intensified form of heart failure management programme (INT-HF-MP) based on individual profiling is superior to standard management (SM) in reducing health care costs during 12-month follow-up (primary endpoint). Methods and results: A multicentre randomized trial involving 787 patients (full analysis set) discharged from four tertiary hospitals with chronic HF who were randomized to SM (n = 391) or INT-HF-MP (n = 396). Mean age was 74 ± 12 years, 65% had HF with a reduced ejection fraction (31...
May 20, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28525640/inflammation-venous-thromboembolism-and-what-we-can-do-about-it
#11
Robert J Glynn, Paul M Ridker
No abstract text is available yet for this article.
May 19, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28525639/readmissions-after-transcatheter-aortic-valve-implantation-what-are-they-doing-right-how-can-we-do-better
#12
Devraj Sukul, David S Bach
No abstract text is available yet for this article.
May 19, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28525583/reduction-of-ldl-c-related-residual-cardiovascular-risk-with-ezetimibe-are-mechanistic-considerations-warranted-in-practice
#13
Karin H Humphries, G B John Mancini
No abstract text is available yet for this article.
May 19, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28525554/hdl-cholesterol-concentration-or-hdl-function-which-matters
#14
Philip J Barter, Kerry-Anne Rye
No abstract text is available yet for this article.
May 19, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28520938/platelet-lipidomics-a-window-of-opportunity-to-assess-cardiovascular-risk
#15
James D McFadyen, Peter J Meikle, Karlheinz Peter
No abstract text is available yet for this article.
May 17, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28520911/anatomic-validation-of-late-gadolinium-enhancement-as-evidence-of-myocardial-scarring-in-lamp2-cardiomyopathy
#16
Ethan J Rowin, Barry J Maron, Knarik Arkun, Martin S Maron
No abstract text is available yet for this article.
May 17, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28510709/clopidogrel-instead-of-prasugrel-or-ticagrelor-after-1%C3%A2-month-in-stabilized-acs-patients-back-to-square-one-for-dapt
#17
Peter R Sinnaeve, Frans Van de Werf
No abstract text is available yet for this article.
May 16, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28510646/benefit-of-switching-dual-antiplatelet-therapy-after-acute-coronary-syndrome-the-topic-timing-of-platelet-inhibition-after-acute-coronary-syndrome-randomized-study
#18
Thomas Cuisset, Pierre Deharo, Jacques Quilici, Thomas W Johnson, Stéphanie Deffarges, Clémence Bassez, Guillaume Bonnet, Laurent Fourcade, Jean Philippe Mouret, Marc Lambert, Valentine Verdier, Pierre Emmanuel Morange, Marie Christine Alessi, Jean Louis Bonnet
Aims: Newer P2Y12 blockers (prasugrel and ticagrelor) demonstrated significant ischaemic benefit over clopidogrel after acute coronary syndrome (ACS). However, both drugs are associated with an increase in bleeding complications. The objective of the present study was to evaluate the benefit of switching dual antiplatelet therapy (DAPT) from aspirin plus a newer P2Y12 blocker to aspirin plus clopidogrel 1 month after ACS. Methods and results: We performed an open-label, monocentric, and randomized trial...
May 16, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28499031/primary-echinococcus-infection-of-the-heart-a-rare-type-of-cystic-echinococcosis
#19
T N C Padmanabhan, K V K Kumar, Mohammed Sadiq Azam, Anil Kumar Bilolikar
No abstract text is available yet for this article.
May 12, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28498942/effect-of-vitamin-d-on-all-cause-mortality-in-heart-failure-evita-a-3-year-randomized-clinical-trial-with-4000%C3%A2-iu-vitamin-d-daily
#20
Armin Zittermann, Jana B Ernst, Sylvana Prokop, Uwe Fuchs, Jens Dreier, Joachim Kuhn, Cornelius Knabbe, Ingvild Birschmann, Uwe Schulz, Heiner K Berthold, Stefan Pilz, Ioanna Gouni-Berthold, Jan F Gummert, Marcus Dittrich, Jochen Börgermann
Aims: Circulating 25-hydroxyvitamin D (25OHD) levels <75 nmol/L are associated with a nonlinear increase in mortality risk. Such 25OHD levels are common in heart failure (HF). We therefore examined whether oral vitamin D supplementation reduces mortality in patients with advanced HF. Methods and results: Four hundred HF patients with 25OHD levels <75 nmol/L were randomized to receive 4000 IU vitamin D daily or matching placebo for 3 years. Primary endpoint was all-cause mortality...
May 12, 2017: European Heart Journal
journal
journal
20101
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"